CD79A and COVID-19: Anti-A IgG and IgA antibody titers (Figures 2A,B) were significantly lower in both symptomatic and combined (asymptomatic + symptomatic) COVID-19 patient groups compared to healthy controls, while no significant difference was observed between asymptomatic and symptomatic patients.